Ambroxol inhibits histamine release from human adenoidal mast cells.
Zwadlo-Klarwasser
G
G
Institute of Pharmacology and Toxicology, Medical Faculty, RWTH, Aachen, Germany.
Servais
M D
MD
Schmutzler
W
W
Brosthardt
P
P
Braam
U
U
D000234:Adenoids / Q000166:cytology / Q000187:drug effects*; D000551:Ambroxol / Q000494:pharmacology*; D018926:Anti-Allergic Agents / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005100:Expectorants / Q000494:pharmacology*; D006098:Granulocytes / Q000187:drug effects / Q000378:metabolism; D006636:Histamine Release / Q000187:drug effects*; D006801:Humans; D007975:Leukotriene B4 / Q000378:metabolism; D008407:Mast Cells / Q000187:drug effects* / Q000378:metabolism; D009000:Monocytes / Q000187:drug effects / Q000378:metabolism; D012867:Skin / Q000187:drug effects; D013481:Superoxides / Q000378:metabolism; D015054:Zymosan; D003189:p-Methoxy-N-methylphenethylamine / Q000633:toxicity
D018926:Anti-Allergic Agents; D005100:Expectorants; D013481:Superoxides; D007975:Leukotriene B4; D000551:Ambroxol; D003189:p-Methoxy-N-methylphenethylamine; D015054:Zymosan